PNRC2 activators comprise a diverse set of chemical compounds that indirectly promote the functional activity of PNRC2 through various cellular signaling pathways. Forskolin, by raising cAMP levels, indirectly enhances PNRC2's activity by activating PKA, which may then phosphorylate and activate PNRC2 or associated proteins. Similarly, the kinase inhibitor Epigallocatechin gallate can decrease kinase-mediated signaling competition, which serves to enhance the functional pathways in which PNRC2 participates. Sphingosine-1-phosphate and Thapsigargin are also pivotal; the former modulates sphingolipid signaling to support PNRC2's role, while the latter raises intracellular calcium that can activate calcium-dependent pathways, consequently promoting PNRC2 activation. PMA, as a potent PKC activator, contributes to the enhancement of pathways that lead to PNRC2 activation.
The activity of PNRC2 is further modulated by compounds that interact with MAPK signaling. A23187 acts by increasing intracellular calcium, a crucial secondary messenger that activates pathways in which PNRC2 is implicated. Genistein, through its tyrosine kinase inhibition, potentially reduces competitive signaling, thus facilitating the pathways that activate PNRC2. Finally, Staurosporine, though a broad-spectrum protein kinase inhibitor, might selectively enhance PNRC2-related pathways by inhibiting kinases that negatively regulate PNRC2's activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels. Elevated cAMP activates PKA, which can phosphorylate PNRC2, enhancing its activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
As a kinase inhibitor, it may reduce competition from other kinase signaling, indirectly enhancing PNRC2 pathway activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
By modulating sphingolipid signaling, it can influence intracellular processes that augment PNRC2 activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
This compound elevates intracellular calcium levels, potentially activating calcium-dependent pathways that increase PNRC2 function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
As a PKC activator, PMA can enhance pathways that lead to the activation of PNRC2. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
By increasing intracellular calcium, A23187 can activate calcium-dependent pathways that increase PNRC2 activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, Genistein may allow PNRC2 pathways to be more active by reducing tyrosine kinase signaling. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
While a broad-spectrum protein kinase inhibitor, Staurosporine may lead to selective activation of pathways involving PNRC2. | ||||||